Staubach P, Melhorn S, Hünerbein A, Peveling-Oberhag A
Hautklinik und Poliklinik, Universitätsmedizin Mainz, Langenbeckstr. 1, 55131, Mainz, Deutschland.
DAC/NRF, Avoxa - Mediengruppe Deutscher Apotheker, Eschborn, Deutschland.
Hautarzt. 2016 Oct;67(10):833-844. doi: 10.1007/s00105-016-3868-1.
Dermatology is in a state of flux, and systemic therapies have changed the prescription practice in the past few years. Nevertheless, topical therapy for dermatological illnesses is still the mainstay of dermatologists. Pharmaceutically manufactured drugs have a wide spectrum and allow for variability. Additionally, there are therapeutic niches that can be bridged by prescribing extemporaneous formulations. This is also true for the newly established basic therapies for many chronic dermatological illnesses which have become essential and are needed in large amounts. Unfortunately, neither during medical school, nor during residency training, not even the basic knowledge or the complexity of these extemporaneous formulations for topical therapy in dermatology is taught. This emphasizes why standardized, proven extemporaneous formulations are vital for physicians to achieve optimal and goal-oriented therapy for their patients. Sensible and effective prescriptions enhance the quality of formulations and the maintenance and well-being of our patients.
皮肤科处于不断变化的状态，在过去几年中，全身治疗已经改变了处方实践。然而，皮肤病的局部治疗仍然是皮肤科医生的主要治疗手段。制药生产的药物种类繁多，具有可变性。此外，通过开具临时配制的制剂可以填补一些治疗空白。对于许多慢性皮肤病新确立的基础治疗也是如此，这些治疗已变得至关重要且需求量大。不幸的是，无论是在医学院期间，还是在住院医师培训期间，甚至都没有教授皮肤科局部治疗这些临时配制制剂的基本知识或复杂性。这就强调了为什么标准化、经过验证的临时配制制剂对于医生为患者实现最佳和目标导向的治疗至关重要。合理有效的处方可提高制剂质量以及我们患者的维持状态和健康水平。
